Axonal Iron Transport might Contribute to Iron Deposition in Parkinson's Disease.
作者信息
Chen Leilei, Li Chong, Xie Junxia
机构信息
Institute of Brain Science and Disease, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, 266071, China.
出版信息
Neurosci Bull. 2021 Feb;37(2):275-277. doi: 10.1007/s12264-020-00585-5. Epub 2020 Sep 22.
Abstract
摘要
相似文献
1
Axonal Iron Transport might Contribute to Iron Deposition in Parkinson's Disease.轴突铁转运可能导致帕金森病中的铁沉积。
Neurosci Bull. 2021 Feb;37(2):275-277. doi: 10.1007/s12264-020-00585-5. Epub 2020 Sep 22.
2
Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.采用定量磁化率映射技术对帕金森病患者黑质内铁沉积进行定量分析。
J Neurol Sci. 2018 Mar 15;386:46-52. doi: 10.1016/j.jns.2018.01.008. Epub 2018 Jan 12.
3
Complex I, iron, and ferritin in Parkinson's disease substantia nigra.帕金森病黑质中的复合体I、铁和铁蛋白。
Ann Neurol. 1994 Dec;36(6):876-81. doi: 10.1002/ana.410360612.
4
Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping.帕金森病患者黑质铁沉积的侧方不对称性及空间差异的定量磁化率成像测量
AJNR Am J Neuroradiol. 2016 May;37(5):782-8. doi: 10.3174/ajnr.A4645. Epub 2016 Jan 28.
5
The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.帕金森病中多巴胺、神经黑色素和铁的时空变化。
Brain. 2021 Nov 29;144(10):3114-3125. doi: 10.1093/brain/awab191.
6
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.血清铜蓝蛋白水平降低特征性地加重帕金森病患者的黑质铁沉积。
Brain. 2011 Jan;134(Pt 1):50-8. doi: 10.1093/brain/awq319. Epub 2010 Nov 24.
7
[Mechanism of α-lipoic acid promoting iron efflux in substantia nigra cells of Parkinson's disease rats].[α-硫辛酸促进帕金森病大鼠黑质细胞铁外流的机制]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018 Jan;34(1):35-40.
8
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.帕金森病患者黑质中铁和铝含量增加：X射线微分析
J Neurochem. 1991 Feb;56(2):446-51. doi: 10.1111/j.1471-4159.1991.tb08170.x.
9
Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.帕金森病黑质 R2* 和弥散张量成像的联合改变。
Mov Disord. 2011 Aug 1;26(9):1627-32. doi: 10.1002/mds.23643. Epub 2011 May 26.
10
Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.采用 3D 增强 T2*加权血管造影术（ESWAN）定量评估中脑铁沉积：20 例帕金森病患者的初步横断面研究。
Magn Reson Imaging. 2013 Sep;31(7):1068-73. doi: 10.1016/j.mri.2013.04.015. Epub 2013 Jun 6.
引用本文的文献
1
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.神经退行性疾病中铁及其他金属离子的稳态与代谢
Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0.
2
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson's Disease via Decreasing Inflammation and Iron Deposition.跨膜蛋白106B基因敲低通过减轻炎症和铁沉积对帕金森病发挥神经保护作用。
Mol Neurobiol. 2025 Feb;62(2):1813-1825. doi: 10.1007/s12035-024-04373-4. Epub 2024 Jul 23.
3
Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.α-突触核蛋白与铁的毒性相互作用诱导的细胞衰老先于帕金森病小鼠模型黑质多巴胺能神经元的丢失。
Acta Pharmacol Sin. 2024 Feb;45(2):268-281. doi: 10.1038/s41401-023-01153-z. Epub 2023 Sep 6.
4
Commentary: The impact of iron deposition on the fear circuit of the brain in patients with Parkinson's disease and anxiety.评论：铁沉积对帕金森病伴焦虑患者大脑恐惧回路的影响
Front Aging Neurosci. 2023 Jun 19;15:1223421. doi: 10.3389/fnagi.2023.1223421. eCollection 2023.
5
Calcium Homeostasis in Parkinson's Disease: From Pathology to Treatment.帕金森病中的钙稳态：从病理到治疗
Neurosci Bull. 2022 Oct;38(10):1267-1270. doi: 10.1007/s12264-022-00899-6. Epub 2022 Jun 21.
6
6-Hydroxydopamine Induces Abnormal Iron Sequestration in BV2 Microglia by Activating Iron Regulatory Protein 1 and Inhibiting Hepcidin Release.6-羟多巴胺通过激活铁调节蛋白 1 和抑制铁调素释放诱导 BV2 小胶质细胞中铁的异常蓄积。
Biomolecules. 2022 Feb 7;12(2):266. doi: 10.3390/biom12020266.
7
Direct Conversion of Astrocytes to Neurons Maybe a Potential Alternative Strategy for Neurodegenerative Diseases.将星形胶质细胞直接转化为神经元可能是神经退行性疾病的一种潜在替代策略。
Front Aging Neurosci. 2021 Aug 2;13:689276. doi: 10.3389/fnagi.2021.689276. eCollection 2021.
8
A Review on Lactoferrin and Central Nervous System Diseases.乳铁蛋白与中枢神经系统疾病研究进展
Cells. 2021 Jul 17;10(7):1810. doi: 10.3390/cells10071810.
本文引用的文献
1
Reversing a model of Parkinson's disease with in situ converted nigral neurons.利用原位转化的黑质神经元逆转帕金森病模型。
Nature. 2020 Jun;582(7813):550-556. doi: 10.1038/s41586-020-2388-4. Epub 2020 Jun 24.
2
Brain iron deposition is linked with cognitive severity in Parkinson's disease.脑铁沉积与帕金森病认知严重程度相关。
J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):418-425. doi: 10.1136/jnnp-2019-322042. Epub 2020 Feb 20.
3
JWH133 inhibits MPP-induced inflammatory response and iron influx in astrocytes.JWH133 抑制 MPP+诱导的星形胶质细胞炎症反应和铁内流。
Neurosci Lett. 2020 Feb 16;720:134779. doi: 10.1016/j.neulet.2020.134779. Epub 2020 Jan 22.
4
Axonal iron transport in the brain modulates anxiety-related behaviors.脑内轴突铁转运调节焦虑相关行为。
Nat Chem Biol. 2019 Dec;15(12):1214-1222. doi: 10.1038/s41589-019-0371-x. Epub 2019 Oct 7.
5
Interactions between iron and α-synuclein pathology in Parkinson's disease.帕金森病中铁与α-突触核蛋白病理之间的相互作用。
Free Radic Biol Med. 2019 Sep;141:253-260. doi: 10.1016/j.freeradbiomed.2019.06.024. Epub 2019 Jun 22.
6
Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach.神经病学疾病中的死后 MRI 和组织病理学：转化方法。
Neurosci Bull. 2019 Apr;35(2):229-243. doi: 10.1007/s12264-019-00342-3. Epub 2019 Feb 21.
7
Iron as a therapeutic target for Parkinson's disease.铁作为帕金森病的治疗靶点。
Mov Disord. 2018 Apr;33(4):568-574. doi: 10.1002/mds.27275. Epub 2018 Jan 30.
8
Astroglial and microglial contributions to iron metabolism disturbance in Parkinson's disease.星形胶质细胞和小胶质细胞在帕金森病中铁代谢紊乱中的作用。
Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):967-973. doi: 10.1016/j.bbadis.2018.01.008. Epub 2018 Jan 6.
9
Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease.帕金森病患者死后大脑颞叶皮质铁含量降低。
Neurology. 2013 Jan 29;80(5):492-5. doi: 10.1212/WNL.0b013e31827f0ebb. Epub 2013 Jan 9.
10
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.二价金属离子转运蛋白1（DMT1）在帕金森病动物模型中会导致神经退行性变。
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18578-83. doi: 10.1073/pnas.0804373105. Epub 2008 Nov 14.
Zotero 插件